Use of testicular sperm in couples with SCSA-defined high sperm DNA fragmentation and failed intracy

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:sony360
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Sperm DNA fragmentation (SDF) has been linked with male infertility,and previous studies suggest that SDF can have negative influence on pregnancy outcomes with assisted reproduction.We performed a retrospective review of consecutive couples with a high SDF level that had intracytoplasmic sperm injection (ICSI) using testicular sperm (T-ICSI).We compared the T-ICSI outcomes to that of two control groups:87 couples with failed first ICSI cycle and who had a second ICSI cycle using ejaculated sperm (Ej-ICSI),and 48 consecutive couples with high sperm chromatin structure assay (SCSA)-defined SDF (>15%) that underwent an ICSI cycle using ejaculated sperm after one or more failed ICSI cycles (Ej-ICSI-high SDF).The mean number of oocytes that were retrieved and the total number of embryos were not different among the three groups.The mean number of transferred embryos in the T-ICSI group was higher than the Ej-ICSI group but not significantly different than the Ej-ICSI-high SDF group (1.4,1.2,and 1.3,respectively,P < 0.05).Clinical pregnancy rate in the T-ICSI group was not significantly different than the Ej-ICSI and Ej-ICSI-high SDF groups (48.6%,48.2%,and 38.7%,respectively,P > 0.05).No significant difference was found in live birth rate when comparing T-ICSI to Ej-ICSI and Ej-ICSI-high SDF groups.The results suggest that pregnancy outcomes and live birth rates with T-ICSI are not significantly superior to Ej-ICSI in patients with an elevated SCSA-defined sperm DNA fragmentation and prior ICSI failure(s).
其他文献
Peripheral nerve damage,such as that found after surgery or trauma,is a substantial clinical challenge.Much research continues in attempts to improve outcomes after peripheral nerve damage and to promote nerve repair after injury.In recent years,lowintens
The pretreatment serum albumin/globulin ratio (AGR) has been used as a prognostic biomarker for various cancer types.However,the prognostic value of the AGR for prostate cancer,especially for metastatic prostate cancer (mPCa) after maximal androgen blocka
In recent years,it has come a long way in the diagnosis,treatment,and follow-up of prostate cancer.Beside this,it was argued that definitive treatments could cause overtreatment,particularly in the very low,low,and favorable risk group.When alternative tr
Circulating tumor cells (CTC) have become an important biomarker in patients with advanced prostate cancer.CTC count has been demonstrated to be a prognostic factor for overall survival in patients with metastatic castration-resistant prostate cancer (mCR
The global population is collectively getting older,and age is directly correlated with erectile dysfunction (ED).With the advent of effective oral agents and wide availability of the Internet,a larger portion of the population is becoming aware of the di
期刊
Mice deficient in the transcription factor pleomorphic adenoma gene 1 (PLAG1) exhibit reproductive issues that are characterized,in part,by decreased progressive sperm motility in the male.However,the underlying cause of this impairment is unknown.As epid
Lycopene is a natural compound that alleviates oxidative stress and inflammation,exerting therapeutic effects in a number of cancers.The aim of this study is to investigate the efficacy of lycopene in inhibiting prostate cancer.Cell viability assays indic
The aim of our study was to investigate the role of platelet parameters including mean platelet volume (MPV) and platelet count (PC) in the pathogenesis of penile arteriogenic erectile dysfunction (ED) and to evaluate the association between the platelet
Aromatase activity has commonly been associated with male infertility characterized by testicular dysfunction with low serum testosterone and/or testosterone to estradiol ratio.In this subset of patients,and particularly in those with hypogonadism,elevate
Reasons for and against screening of prostate cancer have been discussed widely over the last decade.In 2014,the European Randomized Trial for Screening of Prostate Cancer (ERSPC) has reported a relative reduction of the cancer-specific survival of 27% in
期刊